Bell Investment Advisors, Inc - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 262 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.

Quarter-by-quarter ownership
Bell Investment Advisors, Inc ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,902
-64.0%
50
-13.8%
0.00%
-100.0%
Q2 2023$5,284
+38.1%
580.0%0.00%0.0%
Q1 2023$3,826
+48.0%
58
+16.0%
0.00%0.0%
Q4 2022$2,586
-13.8%
500.0%0.00%0.0%
Q3 2022$3,000
+50.0%
500.0%0.00%0.0%
Q2 2022$2,000
-33.3%
50
-18.0%
0.00%0.0%
Q4 2021$3,000
+200.0%
61
+64.9%
0.00%
Q3 2021$1,000370.00%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 2,503,059$170,959,00029.50%
ACUTA CAPITAL PARTNERS, LLC 554,000$37,838,00016.29%
Avoro Capital Advisors LLC 10,125,000$691,538,00012.78%
Sio Capital Management, LLC 507,700$34,676,00011.02%
Logos Global Management LP 1,300,000$88,790,00010.92%
EcoR1 Capital, LLC 5,183,431$354,028,00010.45%
Cormorant Asset Management, LP 1,478,000$100,947,0007.06%
Finepoint Capital LP 266,090$18,174,0005.98%
Ghost Tree Capital, LLC 275,000$18,783,0005.27%
Boxer Capital, LLC 1,303,700$89,043,0005.01%
View complete list of APELLIS PHARMACEUTICALS INC shareholders